Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience.

about

Efficacy and toxicity of chemoradiation in patients with anal cancer--a retrospective analysis.Intensified intensity-modulated radiotherapy in anal cancer with prevalent HPV p16 positivity Concomitant chemoradiotherapy with Cisplatin plus 5-Fluorouracil for anal squamous cell carcinoma.

P2860

Q33646367-7C0F01A1-DA61-4449-B5B1-6681D1598206 Q36105656-9E3DA203-348E-4DCA-AC54-1B3BC5FADD1A Q46310024-8EE5CE61-B166-4994-B792-22F09F003AE6

P2860

Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience.

Item

http://www.wikidata.org/entity/Q36786775

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Chemoradiotherapy in squamous ...... single institution experience.

@en

type

Item

label

Chemoradiotherapy in squamous ...... single institution experience.

@en

prefLabel

Chemoradiotherapy in squamous ...... single institution experience.

@en

P1476

Chemoradiotherapy in squamous ...... single institution experience

@en

P2093

Kyung Hwan Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2001

Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.

Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11)

Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients.

Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base.

Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11.

Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I).

RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal

Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08.

Anal canal carcinoma: experience from a single Korean institution.

P304

25-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3857/ROJ.2013.31.1.25

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236339885

http://www.w3.org/2001/XMLSchema#string

P698

23620866

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

3633228

http://www.w3.org/2001/XMLSchema#string

Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience.

about

P2860

P2860

Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932